A. Birch

发表

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours

C. Greenwood, A. Mes-Masson, D. Provencher, 2011, PloS one.

Real-world genetic screening with molecular ancestry supports comprehensive pan-ethnic carrier screening

Schadt, L. Edelmann, B. Webb, 2022, medRxiv.

Prevalence of four Mendelian disorders associated with autism in 2392 affected families

Y. Trakadis, A. Birch, Avi Saskin, 2017, Journal of Human Genetics.

Lessons learned from expanded reproductive carrier screening in self‐reported Ashkenazi, Sephardi, and Mizrahi Jewish patients

Mitchell W Dillon, E. Schadt, L. Edelmann, 2019, Molecular genetics & genomic medicine.

Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease‐causing variants

L. Edelmann, L. Shi, B. Webb, 2017, Clinical genetics.

Estimating the Prevalence of the Adult Polyglucosan Body Disease at the Gene Level for Ashkenazi Jews in the United States

R. Kornreich, A. Birch, A. Lossos, 2020 .

The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome

C. Greenwood, A. Mes-Masson, J. Madore, 2012, PloS one.

Molecular Genetic Analysis of a Cell Adhesion Molecule With Homology to L1CAM, Contactin 6, and Contactin 4 Candidate Chromosome 3p26pter Tumor Suppressor Genes in Ovarian Cancer

A. Mes-Masson, D. Provencher, P. Tonin, 2009, International Journal of Gynecologic Cancer.

Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes

A. Mes-Masson, D. Provencher, P. Tonin, 2008, Molecular carcinogenesis.

The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles

Anne-Marie Mes-Masson, A. Mes-Masson, D. Provencher, 2009, Journal of Translational Medicine.